Tradestie Institutional Equity Comparison Engine

PULM vs EYEG โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PULM Overall Edge

PULM Captures Institutional Edge (1โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Pulmatrix, Inc. Common Stock (PULM) driven by superior Growth & Margin while EYEG counters with relative strength in Momentum & Technical. Fundamentally, PULM trades at N/M Forward P/E with 0.0% operating margin (-99.9% YoY revenue) versus EYEG at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, PULM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against EYEG sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
PULM N/M vs EYEG N/M Fwd P/E
Growth & Margin Winner PULM
Op Margin 0.0% vs N/A ยท YoY -99.9% vs N/A
Momentum & Technical Winner EYEG
1Y -73.3% vs -6.4% ยท 52W Pos 5% vs 15%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
PULM NASDAQ
Pulmatrix, Inc. Common Stock
Pharmaceutical Preparations
$1.27
-10.56% 1D
Market Cap $5.2M
1M Return -10.56%
1Y Return -73.26%
Forward P/E N/M
Unified AI Score
43.1 / 100 HOLD
Tech 36.0 Fund 61.0 Flow 50.0 Mom 64.0
EYEG US Equity
EYEG
Institutional Equity
$33.73
+0.48% 1D
Market Cap N/A
1M Return +0.42%
1Y Return -6.36%
Forward P/E N/M
Unified AI Score
55.0 / 100 HOLD
Tech 73.0 Fund 61.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PULM -73.26% EYEG -6.36% Spread: +67.35 pp (EYEG Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
PULM TTM Op. Margin: 0.0% EYEG TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PULM vs EYEG. Trailing 12-month operating profitability (PULM 0.0% vs EYEG N/A) and valuation multiples (PULM N/M vs EYEG N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PULM (5) vs EYEG (3)
Institutional Metric PULM EYEG Criterion Row Winner
Market Capitalization Scale $5.2M N/A Larger Scale PULM
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -99.9% N/A Higher Growth PULM
Operating Margin (TTM) Profitability 0.0% N/A Higher Margin PULM
Net Profit Margin Profitability 0.0% N/A Higher Margin PULM
Return on Equity (ROE) Capital Efficiency -143.1% N/A Higher ROE PULM
52-Week Range Position Momentum 5% ($1โ€“$5) 15% ($33โ€“$36) Stronger Trend EYEG
Beta / 30D Volatility Risk Regime 0.82ฮฒ ยท 82% Vol 0.13ฮฒ ยท 5% Vol Lower Realized Risk EYEG
Unified Institutional Score Composite Signal 43.1 / 100 (HOLD) 55.0 / 100 (HOLD) Higher Composite EYEG

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PULM vs EYEG Buy Guide
PULM UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PULM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
EYEG UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live EYEG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PULM nor EYEG registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.